Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:1451:301-316.
doi: 10.1007/978-3-031-57165-7_19.

Treatment and Vaccination for Smallpox and Monkeypox

Affiliations
Review

Treatment and Vaccination for Smallpox and Monkeypox

Klaus P Saalbach. Adv Exp Med Biol. 2024.

Abstract

The smallpox infection with the variola virus was one of the most fatal disorders until a global eradication was initiated in the twentieth century. The last cases were reported in Somalia 1977 and as a laboratory infection in the UK 1978; in 1980, the World Health Organization (WHO) declared smallpox for extinct. The smallpox virus with its very high transmissibility and mortality is still a major biothreat, because the vaccination against smallpox was stopped globally in the 1980s. For this reason, new antivirals (cidofovir, brincidofovir, and tecovirimat) and new vaccines (ACAM2000, LC16m8 and Modified Vaccine Ankara MVA) were developed. For passive immunization, vaccinia immune globulin intravenous (VIGIV) is available. Due to the relationships between orthopox viruses such as vaccinia, variola, mpox (monkeypox), cowpox, and horsepox, the vaccines (LC16m8 and MVA) and antivirals (brincidofovir and tecovirimat) could also be used in the mpox outbreak with positive preliminary data. As mutations can result in drug resistance against cidofovir or tecovirimat, there is need for further research. Further antivirals (NIOCH-14 and ST-357) and vaccines (VACΔ6 and TNX-801) are being developed in Russia and the USA. In conclusion, further research for treatment and prevention of orthopox infections is needed and is already in progress. After a brief introduction, this chapter presents the smallpox and mpox disease and thereafter full overviews on antiviral treatment and vaccination including the passive immunization with vaccinia immunoglobulins.

Keywords: Brincidofovir; Immunoglobulins; Monkeypox; Mpox; Orthopox; Smallpox; Tecovirimat; Vaccinia; Variola; Virokines.

PubMed Disclaimer

Similar articles

References

    1. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, Osborne JC, Rampling T, Beadsworth MBJ, Duncan CJA, Dunning J, Fletcher TE, Hunter ER, Jacobs M, Khoo SH, Newsholme W, Porter D, Porter RJ, Ratcliffe L, Schmid ML, Semple MG, Tunbridge AJ, Wingfield T, Price NM (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22:1153–1162. https://doi.org/10.1016/S1473-3099(22)00228-6 - DOI - PubMed - PMC
    1. Andrei G, Snoeck R (2010) Cidofovir activity against poxvirus infections. Viruses 2:2803–2830. https://doi.org/10.3390/v2122803 - DOI - PubMed - PMC
    1. CDC (2022a) Expanded Access IND Protocol: use of tecovirimat (TPOXX®) for treatment of human non-variola orthopoxvirus infections in adults and children (IND No. 116,039). Centers for Disease Control and Prevention, United States. https://www.cdc.gov/poxvirus/monkeypox/pdf/tecovirimat-ind-protocol-cdc-... . Accessed: 2 Jan 2023
    1. CDC (2022b) Expanded Access IND Protocol: Use of Vaccinia Immune Globulin Intravenous (VIGIV, CNJ-016) for treatment of human Orthopoxvirus infection in adults and children (BB-IND No. 10788). Centers for Disease Control and Prevention, United States. https://www.cdc.gov/poxvirus/monkeypox/pdf/vigiv-ind-protocol.pdf . Accessed: 2 Jan 2023
    1. ECDC (2023) Mpox (formerly named monkeypox) situation update, as of 3 January 2022. European Centre for Disease Prevention and Control (ECDC), Stockholm. https://www.ecdc.europa.eu/en/news-events/monkeypox-situation-update . Accessed: 4 Jan 2023

MeSH terms

LinkOut - more resources